• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF).

作者信息

Millar Beverley Cherie, Malnarcic Camila M, McCaughan John, Moore John E

机构信息

Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK.

School of Medicine, Dentistry and Biomedical Science, The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK.

出版信息

Clin Respir J. 2020 Jan;14(1):64-68. doi: 10.1111/crj.13100. Epub 2019 Nov 14.

DOI:10.1111/crj.13100
PMID:31663261
Abstract
摘要

相似文献

1
Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF).美国临床和实验室标准协会（CLSI）关于环丙沙星和左氧氟沙星对铜绿假单胞菌敏感性标准的重新分类：对囊性纤维化（CF）患者的影响。
Clin Respir J. 2020 Jan;14(1):64-68. doi: 10.1111/crj.13100. Epub 2019 Nov 14.
2
Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.针对铜绿假单胞菌的左氧氟沙星肺部递药的定制纳米载体：一项对比研究。
Mol Pharm. 2019 May 6;16(5):1906-1916. doi: 10.1021/acs.molpharmaceut.8b01256. Epub 2019 Apr 4.
3
Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis.
Eur Respir J. 2015 Sep;46(3):862-5. doi: 10.1183/09031936.00225914. Epub 2015 Apr 16.
4
Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.北爱尔兰囊性纤维化患者分离出的铜绿假单胞菌和嗜麦芽窄食单胞菌对左氧氟沙星和环丙沙星的体外药敏比较。
Br J Biomed Sci. 2005;62(1):30-2. doi: 10.1080/09674845.2005.11978067.
5
Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.依伐卡托是否会干扰常用抗生素对铜绿假单胞菌的抗菌活性？——一项体外研究的结果。
J Clin Pharm Ther. 2018 Dec;43(6):836-843. doi: 10.1111/jcpt.12722. Epub 2018 Jun 29.
6
Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.德拉沙星——一种治疗囊性纤维化患者对环丙沙星耐药铜绿假单胞菌的新型氟喹诺酮类药物。
Clin Respir J. 2021 Jan;15(1):116-120. doi: 10.1111/crj.13262. Epub 2020 Sep 7.
7
Antibiotic resistance evolution of Pseudomonas aeruginosa in cystic fibrosis patients (2010-2013).囊性纤维化患者中铜绿假单胞菌的抗生素耐药性演变（2010 - 2013年）
Clin Respir J. 2018 Jul;12(7):2189-2196. doi: 10.1111/crj.12787. Epub 2018 Apr 1.
8
Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.亚优化环丙沙星剂量可能导致囊性纤维化患儿铜绿假单胞菌敏感性降低。
Pharmacotherapy. 2010 Dec;30(12):1252-8. doi: 10.1592/phco.30.12.1252.
9
In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.对可用于囊性纤维化（CF）患者肺部感染口服治疗的药物抗菌活性的体外研究。
J Antimicrob Chemother. 1998 Aug;42(2):171-8. doi: 10.1093/jac/42.2.171.
10
Impact of a Reduction in Susceptibility Testing for in a Cystic Fibrosis Program.囊性纤维化项目中药敏试验减少的影响。
Am J Respir Crit Care Med. 2020 Jan 1;201(1):114-116. doi: 10.1164/rccm.201903-0576LE.

引用本文的文献

1
Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells.优化吸入性脂质体粉末制剂，并评估其在 Calu-3 人肺上皮细胞中的体外药物传递行为。
Int J Pharm. 2020 Aug 30;586:119570. doi: 10.1016/j.ijpharm.2020.119570. Epub 2020 Jun 25.